Loading
A phase 2 trial of camrelizumab in colorectal cancer, run by Harbin Medical University, not yet recruiting.
Treatment of Rectal Cancer With Long-term Concurrent Chemoradiotherapy Combined With Camrelizumab is a phase 2, interventional study registered as NCT06304545 by Harbin Medical University, with a registry enrolment figure of 48 participants, started 2024-03-15 and due to reach its primary completion in 2026-08-16. Interventions recorded: Camrelizumab; Chemotherapy; Radiotherapy. Conditions listed: Rectal Cancer. Primary outcome: Pathological Complete Response rate. Colorectal eligibility wording from the registry: "Histologically or cytologically confirmed rectal cancer with measurable tumour lesions (Spiral CT or MR scans ≥ 10 mm, meeting RECIST 1". No results are recorded here; the registry entry is the source.
Shares Camrelizumab, IMRT / IGRT (modern external beam), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Camrelizumab, Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares Camrelizumab, Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares IMRT / IGRT (modern external beam), Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares Camrelizumab, Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares IMRT / IGRT (modern external beam), Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares IMRT / IGRT (modern external beam), Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares IMRT / IGRT (modern external beam), Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.